Fortunately, there are some strategies that might help in bringing that total down
These mechanisms evolved to protect against starvation but become problematic in environments of food abundance
First identified in the 1990s during research into gastric mucosal protection, BPC-157 has since been studied in numerous animal models for its seemingly broad healing properties
Merlo A, DElia E, Di Odoardo L, Sciatti E, Senni M
According to data from Phase 2 clinical trials, patients reported minor adverse events (AEs) at the following rates [2]: Headaches (11%) Facial flushing (20.4%) Nausea (39.9%) According to the results of a longer phase 3 clinical trial, lasting 52-weeks, patients reported AEs at the following rates [9]: Nausea (40.4%) Headache (12.0%) Flushing (20.6%) The only serious AE to occur during long-term (open-label) PT-141 trials was nausea and it was not severe enough to warrant medical attention [9]
MIDDLE EAST GLUTATHIONE MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION) TABLE 340